# EDGAR Filing Document

**Accession Number:** 0000355811
**File Stem:** 0000355811-26-000005
**Filing Date:** 2026-1
**Character Count:** 43022
**Document Hash:** 9a8ea7b8a56599f9c805ac2f45e8a08c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000355811-26-000005.hdr.sgml**: 20260130

**ACCESSION NUMBER**: 0000355811-26-000005

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260130

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260130

**DATE AS OF CHANGE**: 20260130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENTEX CORP
- **CENTRAL INDEX KEY:** 0000355811
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 382030505
- **STATE OF INCORPORATION:** MI
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-10235
- **FILM NUMBER:** 26580571

**BUSINESS ADDRESS:**
- **STREET 1:** 600 N CENTENNIAL ST
- **CITY:** ZEELAND
- **STATE:** MI
- **ZIP:** 49464
- **BUSINESS PHONE:** 6167721800

**MAIL ADDRESS:**
- **STREET 1:** 600 N CENTENNIAL STREET
- **CITY:** ZEELAND
- **STATE:** MI
- **ZIP:** 49464

?xml version='1.0' encoding='ASCII'? gntx-20260130

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

Date of Report: January 30, 2026

**GENTEX CORPORATION** 

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Michigan** | **0-10235** | **38-2030505** |
| (State or other jurisdiction<br>of incorporation) | (Commission<br>File Number) | (IRS Employer<br>Identification No.) |
| **600 North Centennial Street** | | |
| **Zeeland** | | |
| **Michigan** | | **49464** |
| (Address of principal executive offices) | | (Zip Code) |

---

Registrant's telephone number, including area code: **(616) 772-1800** 

_____________________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below):

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.06 per share | GNTX | NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐&nbsp;&nbsp;&nbsp;&nbsp;

------

**Section 2. &nbsp;&nbsp;&nbsp;&nbsp;Financial Information**

**Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)On January 30, 2026, Gentex Corporation issued a news release announcing financial results for the fourth quarter and year ended December 31, 2025. A copy of the news release is attached as Exhibit 99.1 to the Form 8-K.

The information in this Form 8-K and the attached Exhibit shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

**Section 9.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibit

&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;99.1 – News Release Dated January 30, 2026.

<u>SIGNATURE</u>

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: January 30, 2026

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

GENTEX CORPORATION

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

By&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ Kevin C. Nash</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Kevin C. Nash

Its Vice President - Finance and Chief Financial Officer&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;

------

**<u>EXHIBIT INDEX</u>**

&nbsp;&nbsp;&nbsp;&nbsp;<u>[99.1](exhibit99112312025.htm)</u>&nbsp;&nbsp;&nbsp;&nbsp;News Release Dated January 30, 2026

## Exhibit 99.1

**Exhibit 99.1**

![imagea.jpg](imagea.jpg)

**GENTEX REPORTS FOURTH QUARTER AND YEAR END 2025 FINANCIAL RESULTS**

Zeeland, Michigan, January 30, 2026 - Gentex Corporation (NASDAQ: GNTX), a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics, today reported financial results for the fourth quarter and calendar year ended December 31, 2025.

**<u>Fourth Quarter and Calendar Year 2025 Highlights:</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Fourth Quarter 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Net Sales: Consolidated $644.4 million; Core Gentex (ex-VOXX) $541.0 million**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Gross Margin: Consolidated 34.8%; Core Gentex (ex-VOXX) 35.5%**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Income from Operations: Consolidated $120.1 million**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Net Income attributable to Gentex: Consolidated $93.0 million** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Consolidated earnings per diluted share attributable to Gentex: $0.43**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• Calendar Year 2025**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Net Sales: Consolidated $2.53 billion; Core Gentex (ex- VOXX) $2.27 billion**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Gross Margin: Consolidated 34.2%; Core Gentex (ex-VOXX) 34.7%**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Income from Operations: Consolidated $473.9 million**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Net income attributable to Gentex: Consolidated $384.8 million**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Earnings per diluted share attributable to Gentex: Consolidated $1.74**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**◦ Capital returned to shareholders: $425.9 million (35% increase vs. 2024)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**▪ $319.0 million in share repurchases (13.6 million shares)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**• $106.9 million in dividends**

**<u>Fourth Quarter 2025</u>**&nbsp;&nbsp;&nbsp;&nbsp;

For the fourth quarter of 2025, the Company reported consolidated net sales of $644.4 million, an increase of 19% compared to net sales of $541.6 million for the fourth quarter of 2024. VOXX contributed $103.4 million of revenue during the fourth quarter, and core Gentex revenue was $541.0 million, approximately flat compared with revenue in the fourth quarter of 2024 (which also excluded VOXX), despite a 2% decline in light vehicle production quarter-over-quarter in the Company's primary markets of North America, Europe, and Japan/Korea. "While core Gentex revenue was essentially flat compared to the fourth quarter of last year, our performance within our primary markets was notably stronger. Revenue in these regions grew approximately 3% quarter-over-quarter, compared to a 2% decline in light-vehicle production, representing a five-point outperformance relative to the underlying market. Sales into China totaled approximately $34.5 million for the quarter despite the impact from tariffs and counter-tariffs

------

**Exhibit 99.1**

that have impacted our exports into the China market. In addition, VOXX delivered over $100 million in revenue in large part due to seasonal sales that contributed significantly to our strong revenue performance during the quarter." said Steve Downing, President and CEO of Gentex Corporation.

The consolidated gross margin in the fourth quarter of 2025 was 34.8%, compared with a gross margin of 32.5% in the fourth quarter of 2024, which did not include VOXX. The core Gentex gross margin was 35.5% in the fourth quarter of 2025, representing a 300 basis-point increase compared to the fourth quarter of 2024. The increase in gross margin in the fourth quarter of 2025 resulted primarily from favorable product mix, continuing operational efficiencies, and purchasing cost reductions, partially offset by tariff-related costs. "In the fourth quarter, core Gentex gross margin improved by 300 basis points versus the prior year, ending at 35.5% for the quarter, and representing the highest gross margin achieved by the Company in a quarter since the first half of 2021," said Downing. "The steady improvement in gross margin reflects the Company's disciplined focus on cost control, productivity, and execution. Over the last couple of years, we established and announced a target of getting back to the 35 - 36% gross margin range and the team has accomplished this goal through unbelievable grit and determination, despite external headwinds. It is also important to note that the gross margin improvement was partially offset by incremental tariff-related costs, which reduced gross margin by approximately 150 basis points (net of recoveries) compared to the fourth quarter of 2024," said Downing.

Consolidated operating expenses during the fourth quarter of 2025 were $104.4 million, compared to operating expenses of $86.5 million in the fourth quarter of 2024, which did not include VOXX. The increase was primarily due to the VOXX acquisition, which accounted for $24.6 million of the increase. Core Gentex operating expenses (excluding VOXX) were $79.8 million in the fourth quarter of 2025, compared to $86.5 million during the fourth quarter of 2024. The fourth quarter of 2024 included impairment charges of $8.9 million related to goodwill and certain intangible assets, which did not repeat in 2025. During the fourth quarter of 2025, core Gentex operating expenses included $0.8 million in Gentex-specific severance expenses. "In addition to the progress we have made in improving gross margins, the Company has also taken deliberate steps to improve our operating cost structure. Over the past several quarters, we have implemented early-retirement programs aimed at decreasing headcount and reduced third-party spend to lower ongoing operating expenses, while maintaining the organizational capacity needed to advance our key technology and product initiatives. These actions position Gentex to continue investing in the innovations that are necessary to support our long-term growth trajectory," said Gentex COO and CTO, Neil Boehm.

Consolidated income from operations for the fourth quarter of 2025 was $120.1 million, compared to income from operations of $89.8 million for the fourth quarter of 2024, which did not include VOXX. Core Gentex income

------

**Exhibit 99.1**

from operations (excluding VOXX) was $112.5 million in the fourth quarter of 2025, representing a 25.3% increase versus the fourth quarter of 2024.

Total other loss was $8.7 million during the fourth quarter of 2025, compared to other income of $8.0 million in the fourth quarter of 2024. During the fourth quarter of 2025, this other loss included an impairment loss related to certain investments and adjustments to credit loss reserves against select loans receivable. In comparison, the fourth quarter of 2024 included a gain resulting from the fair value adjustment of the Company's original investment in VOXX.

During the fourth quarter of 2025, the Company had an effective tax rate of 16.3%, compared to an effective tax rate of 10.3% in the fourth quarter of 2024. The increase was driven by lower tax benefits related to stock-based compensation compared to the fourth quarter of 2024, as well as a reduced benefit from the Foreign-Derived Intangible Income ("FDII") deduction.

In the fourth quarter of 2025, consolidated net income attributable to Gentex was $93.0 million, compared to $87.7 million in the fourth quarter of 2024. Consolidated net income attributable to core Gentex (excluding VOXX) was $86.5 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings per diluted share attributable to Gentex in the fourth quarter of 2025 were $0.43, compared with earnings per diluted share attributable to Gentex of $0.39 in the fourth quarter of 2024, which did not include VOXX.

**<u>Calendar Year 2025</u>**

For calendar year 2025, the Company's consolidated net sales were $2.53 billion, an increase of 10% compared to net sales of $2.31 billion in calendar year 2024. The Company completed its acquisition of VOXX on April 1, 2025 and included VOXX's results in the Company's financial statements beginning at the start of the second quarter of calendar year 2025. Core Gentex sales were $2.27 billion for calendar year 2025, a 2% decline versus calendar year 2024, primarily driven by tariff and counter-tariff actions and the resulting reduction in demand for exports of the Company's products into the China market. In the Company's primary regions — North America, Europe, and Japan/Korea — revenues increased approximately 1% year-over-year for calendar year 2025, despite a 1% decline in light-vehicle production in those same markets compared to 2024.

For calendar year 2025, the consolidated gross margin was 34.2%, compared to a gross margin of 33.3% for calendar year 2024, which did not include VOXX. The core Gentex gross margin was 34.7%, representing a 140 basis-point increase compared to calendar year 2024. Gross margin improvements were primarily the result of purchasing cost reductions, continuing operational efficiencies, and favorable product mix, which were partially offset by tariff related costs that were not reimbursed during the year. "The gross margin expansion during calendar year 2025 was exceptional performance for the Company, especially when considering that the 140 basis-point gain

------

**Exhibit 99.1**

was achieved despite lower sales on a year-over-year basis and new tariff-related headwinds that were not fully offset during the year," concluded Downing.

For calendar year 2025, consolidated operating expenses increased 26% to $392.8 million, compared to $311.4 million for calendar year 2024, which did not include VOXX. VOXX accounted for $74.3 million of the year-over-year change. Core Gentex operating expenses were $318.5 million, for calendar year 2025 in comparison to the $311.4 million in 2024. Calendar year 2025 operating expenses included $10.4 million in Gentex-specific severance expenses.

Total other loss was $12.9 million during calendar year 2025, compared to other income of $12.5 million in calendar year 2024.

For calendar year 2025, the Company's effective tax rate was 16.6%, compared to an effective tax rate of 14.3% for calendar year 2024. The rate increase was driven by reduced tax benefits related to stock-based compensation compared to calendar year 2024, as well as a lower benefit from the FDII deduction.

Consolidated net income attributable to Gentex for calendar year 2025 was $384.8 million, compared to net income attributable to Gentex of $404.5 million in calendar year 2024, which did not include VOXX.

Earnings per diluted share attributable to Gentex for calendar year 2025 were $1.74, compared to earnings per diluted share of $1.76 in calendar year 2024, which did not include VOXX.

**<u>Revenue by Category</u>**

**<u>Gentex Automotive</u>** 

Gentex Automotive net sales during the fourth quarter of 2025 were $527.6 million, down less than 1% versus $531.3 million in the fourth quarter of 2024, compared with a quarter-over-quarter decline in auto-dimming mirror shipments of 3%. For calendar year 2025, Gentex Automotive net sales were $2.22 billion, also slightly down compared to $2.26 billion in 2024, compared with a year-over-year decline in auto-dimming mirror shipments of 6%.

Other net sales in the fourth quarter of 2025, which includes dimmable aircraft windows, fire protection products, medical products, and biometric products were $13.3 million, compared to Other net sales of $10.3 million in the fourth quarter of 2024. Other net sales for calendar year 2025 were $51.1 million, compared to Other net sales of $48.6 million in calendar year 2024.

**<u>VOXX</u>**

VOXX net sales contributed $103.4 million during the fourth quarter of 2025 and $267.2 million for calendar year 2025. The fourth quarter reflected a seasonal and sequential increase consistent with holiday-period demand.

------

**Exhibit 99.1**

Post-acquisition integration remains on track, with the Company aligning product strategies, furthering customer engagement, and pursuing operational synergies across the combined businesses.

**<u>Share Repurchases</u>**

The Company repurchased 3.8 million shares of its common stock during the fourth quarter of 2025, at an average price of $23.43 per share. For the year ended December 31, 2025, the Company repurchased 13.6 million shares of its common stock at an average price of $23.48 per share, for a total of $319.0 million. As of December 31, 2025, the Company has 35.9 million shares remaining available for repurchase pursuant to its previously announced share repurchase plan. The Company intends to continue to repurchase additional shares of its common stock in the future in support of the previously disclosed capital allocation strategy, but share repurchases may vary from time to time and will take into account macroeconomic issues, market trends, and other factors that the Company deems appropriate.

**<u>Future Estimates</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company's 2026 and 2027 light-vehicle production assumptions reflect the S&P Global Mobility mid-January 2026 forecast for North America, Europe, Japan/Korea, and China (see table below). Based on the S&P Global Mobility forecast, market conditions in our primary markets, the continued impacts on the China market from tariffs, and the expected incremental sales contribution from the VOXX acquisition, the Company is providing detailed annual guidance for 2026 and revenue guidance for 2027:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Light Vehicle Production (per S&P Global Mobility mid-January light vehicle production forecast)** | **Light Vehicle Production (per S&P Global Mobility mid-January light vehicle production forecast)** | **Light Vehicle Production (per S&P Global Mobility mid-January light vehicle production forecast)** | **Light Vehicle Production (per S&P Global Mobility mid-January light vehicle production forecast)** | **Light Vehicle Production (per S&P Global Mobility mid-January light vehicle production forecast)** | **Light Vehicle Production (per S&P Global Mobility mid-January light vehicle production forecast)** |
| ***(in Millions)*** | ***(in Millions)*** | ***(in Millions)*** | ***(in Millions)*** | ***(in Millions)*** | ***(in Millions)*** |
| **Region** | **Calendar Year 2027** | **Calendar Year 2026** | **Calendar Year 2025** | **2027 vs. 2026 % Change** | **2026 vs. 2025 % Change** |
| North America | 15.5 | 15.0 | 15.3 | 3% | (2)% |
| Europe | 17.2 | 16.9 | 17.0 | 2% | (1)% |
| Japan and Korea | 11.6 | 11.9 | 12.1 | (3)% | (2)% |
| China | 32.8 | 32.7 | 33.1 | —% | (1)% |
| Total Light Vehicle Production | 77.1 | 76.5 | 77.5 | 1% | (1)% |

---

---

| | |
|:---|:---|
| ***2026 Consolidated Guidance*** | ***2026 Consolidated Guidance*** |
| Revenue | $2.60 - $2.70 Billion |
| Gross Margin | 34% - 35% |
| Operating Expenses (E,R&D and S,G&A) | $410 - $420 million |
| Estimated Annual Tax Rate | 16% - 18% |
| Capital Expenditures | $125 - $140 million |
| Depreciation & Amortization | $100 - $110 million |

---

------

**Exhibit 99.1**

&nbsp;&nbsp;&nbsp;&nbsp; Additionally, based on the mid-January 2026 S&P Global Mobility light-vehicle production outlook and the Company's estimates for premium audio, aerospace, medical, fire protection, and consumer electronic products, the Company currently expects calendar-year 2027 revenue between $2.75 and $2.85 billion.

**<u>Safe Harbor for Forward-Looking Statements</u>**

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The statements contained in this communication that are not purely historical are forward-looking statements. Forward-looking statements give the Company's current expectations or forecasts of future events. These forward-looking statements generally can be identified by the use of words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "future," "goal," "guidance," "hope," "intend," "likely", "may," "opinion," "optimistic," "plan," "poised," "predict," "project," "should," "strategy," "target," "will," "work to," and variations of such words and similar expressions. Such statements are subject to risks and

------

**Exhibit 99.1**

uncertainties that are often difficult to predict and beyond the Company's control, and could cause the Company's results to differ materially from those described. These risks and uncertainties include, without limitation: changes in general industry or regional market conditions, including the impact of inflation; changes in consumer and customer preferences for our products (such as cameras replacing mirrors and/or autonomous driving); our ability to be awarded new business; continued uncertainty in pricing negotiations with customers and suppliers; loss of business from increased competition; changes in strategic relationships; customer bankruptcies or divestiture of customer brands; fluctuation in vehicle production schedules (including the impact of customer employee strikes); changes in product mix; raw material and other supply shortages; labor shortages, supply chain constraints and disruptions; our dependence on information systems; higher raw material, fuel, energy and other costs; unfavorable fluctuations in currencies or interest rates in the regions in which we operate; costs or difficulties related to the integration and/or ability to maximize the value of any new or acquired technologies and businesses; changes in regulatory conditions; increased competition, seasonal consumer shopping patterns, and changes in the retail industry for products such as consumer electronics, warranty and recall claims and other litigation and customer reactions thereto; possible adverse results of pending or future litigation or infringement claims; changes in tax laws; import and export duty and tariff rates in or with the countries with which we conduct business; negative impact of any governmental investigations and associated litigation, including securities litigation relating to the conduct of our business; and force majeure events. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made.

The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law or the rules of the NASDAQ Global Select Market. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties identified under the heading "Risk Factors" in the Company's latest Form 10-K and Form 10-Q filed with the SEC, which risks and uncertainties include tariffs and supply chain constraints that have affected, are affecting, and will continue to affect, general economic and industry conditions, customers, suppliers, and the regulatory environment in which the Company operates. Includes content supplied by S&P Global Mobility Light Vehicle Production Forecast of January 14, 2026 (http://www.gentex.com/forecast-disclaimer).

**<u>Fourth Quarter Conference Call</u>**

&nbsp;&nbsp;&nbsp;&nbsp;A conference call related to this news release will be simulcast live on the Internet beginning at 9:30 a.m. ET today, January 30, 2026. Participants who wish to ask questions may register for the call at <u>https://register-conf.media-server.com/register/BI3d3ee7554e8c40faa134b994937949db</u> to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that participants join 10 minutes prior to the event start,

------

**Exhibit 99.1**

although they may register ahead of the call and dial in at any time during the call. Participants may listen to the call via audio streaming at <u>https://edge.media-server.com/mmc/p/kz9zbxco</u>. A webcast replay will be available approximately 24 hours after the conclusion of the call at <u>https://ir.gentex.com/events-and-presentations/upcoming-past-events</u>.

**<u>About the Company</u>**

&nbsp;&nbsp;&nbsp;&nbsp;Founded in 1974, Gentex Corporation (The NASDAQ Global Select Market: GNTX) is a leading supplier of digital vision, connected car, dimmable glass, fire protection technologies, medical devices, and consumer electronics. Visit the Company's web site at <u>www.gentex.com</u>.

Contact Information:

Gentex Investor & Media Contact

Josh O'Berski

616.931.3505 <br>

------

**Exhibit 99.1**

**GENTEX CORPORATION**

**AUTO-DIMMING MIRROR SHIPMENTS**

***(Thousands)***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **<br>Three Months Ended <br>December 31,** | **<br>Three Months Ended <br>December 31,** | **<br>Three Months Ended <br>December 31,** | **Twelve Months ended <br>December 31,** | **Twelve Months ended <br>December 31,** | **Twelve Months ended <br>December 31,** |
| | **2025** | **2024** | **%<br> Change** | **2025** | **2024** | **%<br> Change** |
| North American Interior Mirrors | 1971 | 2004 | (2)% | 8726 | 8903 | (2)% |
| North American Exterior Mirrors | 1400 | 1434 | (2)% | 5840 | 6292 | (7)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total North American Mirror Units | 3371 | 3438 | (2)% | 14566 | 15195 | (4)% |
| International Interior Mirrors | 4533 | 4683 | (3)% | 19882 | 20996 | (5)% |
| International Exterior Mirrors | 2558 | 2656 | (4)% | 10378 | 11464 | (9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total International Mirror Units | 7091 | 7339 | (3)% | 30259 | 32460 | (7)% |
| Total Interior Mirrors | 6504 | 6688 | (3)% | 28608 | 29899 | (4)% |
| Total Exterior Mirrors | 3958 | 4090 | (3)% | 16217 | 17755 | (9)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Auto-Dimming Mirror Units | 10462 | 10777 | (3)% | 44825 | 47654 | (6)% |

---

 *Note: Percent change and amounts may not total due to rounding.*

------

**Exhibit 99.1**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **GENTEX CORPORATION AND SUBSIDIARIES** | **GENTEX CORPORATION AND SUBSIDIARIES** |
| | | | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** |
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| | **Three Months Ended December 31, 2025** | **Three Months Ended December 31, 2025** | **Three Months Ended December 31, 2025 and 2024** | **Three Months Ended December 31, 2025 and 2024** |
| | **Supplemental Information** | **Supplemental Information** | **Consolidated** | **Consolidated** |
| | **Gentex** | **VOXX** | **2025** | **2024** |
| Net Sales | $540956599 | $103445011 | $644401610 | $541637568 |
| &nbsp;&nbsp;&nbsp;Cost of Goods Sold | 348685192 | 71198705 | 419883897 | 365411929 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Profit | 192271407 | 32246306 | 224517713 | 176225639 |
| &nbsp;&nbsp;&nbsp;Engineering, Research & Development | 47183757 | 6045651 | 53229408 | 47063273 |
| &nbsp;&nbsp;&nbsp;Selling, General & Administrative | 31807972 | 17925458 | 49733430 | 30529575 |
| &nbsp;&nbsp;&nbsp;Severance Expense | 828770 | 624530 | 1453300 |  |
| &nbsp;&nbsp;&nbsp;Impairment Charges |  |  |  | 8864704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating Expenses | 79820499 | 24595639 | 104416138 | 86457552 |
| &nbsp;&nbsp;&nbsp;Income from Operations | 112450908 | 7650667 | 120101575 | 89768087 |
| &nbsp;&nbsp;&nbsp;Other (Loss)/Income | (6279453) | (2428136) | (8707589) | 8011340 |
| Income before Income Taxes | 106171455 | 5222531 | 111393986 | 97779427 |
| Income Tax Provision (Benefit) | 19647898 | (1524790) | 18123108 | 10111877 |
| Net Income | $86523557 | $6747321 | $93270878 | $87667550 |
| Less: Net income attributable to non-controlling interest |  | 311050 | 311050 |  |
| Net Income Attributable to Gentex Corporation | $86523557 | $6436271 | $92959828 | $87667550 |
| Earnings Per Share Attributable to Gentex Corporation<sup>(1)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $0.40 | $0.03 | $0.43 | $0.39 |
| &nbsp;&nbsp;&nbsp;Diluted | $0.40 | $0.03 | $0.43 | $0.39 |
| Cash Dividends Declared per Share |  |  | $0.120 | $0.120 |
| &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. |

---

------

**Exhibit 99.1**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **GENTEX CORPORATION AND SUBSIDIARIES** | **GENTEX CORPORATION AND SUBSIDIARIES** |
| | | | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME** |
| | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** | **(Unaudited)** |
| | **Twelve Months Ended December 31, 2025** | **Twelve Months Ended December 31, 2025** | **Twelve Months Ended December 31, 2025 and 2024** | **Twelve Months Ended December 31, 2025 and 2024** |
| | **Supplemental Information** | **Supplemental Information** | **Consolidated** | **Consolidated** |
| | **Gentex** | **VOXX** | **2025** | **2024** |
| Net Sales | $2267070341 | $267198624 | $2534268965 | $2313314333 |
| &nbsp;&nbsp;&nbsp;Cost of Goods Sold | 1479671267 | 187888758 | 1667560025 | 1542224143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Profit | 787399074 | 79309866 | 866708940 | 771090190 |
| &nbsp;&nbsp;&nbsp;Engineering, Research & Development | 185259104 | 18000652 | 203259756 | 181475221 |
| &nbsp;&nbsp;&nbsp;Selling, General & Administrative | 122761305 | 55107387 | 177868692 | 121023692 |
| &nbsp;&nbsp;&nbsp;Severance Expense | 10432974 | 1211764 | 11644738 |  |
| &nbsp;&nbsp;&nbsp;Impairment Charges |  |  |  | 8864704 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating Expenses | 318453383 | 74319803 | 392773186 | 311363617 |
| &nbsp;&nbsp;Income from Operations | 468945691 | 4990063 | 473935754 | 459726573 |
| &nbsp;&nbsp;&nbsp;Other (Loss)/Income | (12882248) | 8909 | (12873339) | 12487110 |
| Income Before Income Taxes | 456063443 | 4998972 | 461062415 | 472213683 |
| Income Tax Provision (Benefit) | 77348873 | (968535) | 76380338 | 67725940 |
| Net Income | $378714570 | $5967507 | $384682077 | $404487743 |
| Less: Net loss attributable to non-controlling interest |  | (159290) | (159290) |  |
| Net Income Attributable to Gentex Corporation | $378714570 | $6126797 | $384841367 | $404487743 |
| Earnings Per Share Attributable to Gentex Corporation<sup>(1)</sup> |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | $1.71 | $0.03 | $1.74 | $1.77 |
| &nbsp;&nbsp;&nbsp;Diluted | $1.71 | $0.03 | $1.74 | $1.76 |
| Cash Dividends Declared per Share |  |  | $0.480 | $0.480 |
| &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. | &nbsp;&nbsp;&nbsp;&nbsp;<sup>(1)</sup> Earnings Per Share has been adjusted to exclude the portion of net income allocated to participating securities as a result of share-based payment awards. |

---

Core Gentex (excluding VOXX) information is supplemental, for informational purposes, and is not a separate reportable segment.

------

**Exhibit 99.1**

**GENTEX CORPORATION AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2024** |
| ASSETS |  |  |
| Cash and Cash Equivalents | $145645715 | $233318766 |
| Short-Term Investments | 5386566 | 22304829 |
| Accounts Receivable, net | 368517569 | 295344353 |
| Inventories | 516253617 | 436497445 |
| Other Current Assets | 92631001 | 49862777 |
| Total Current Assets | 1128434468 | 1037328170 |
| Plant and Equipment - Net | 790935378 | 728481467 |
| Goodwill | 357211919 | 340668927 |
| Long-Term Investments | 272975939 | 339604044 |
| Intangible Assets | 189341387 | 195157160 |
| Deferred Tax Asset | 108338592 | 53154832 |
| Patents and Other Assets | 81355151 | 66426375 |
| Total Other Assets | 1009222988 | 995011338 |
| Total Assets | $2928592834 | $2760820975 |
| LIABILITIES AND SHAREHOLDERS' INVESTMENT |  |  |
| Current Liabilities | $387542969 | $252692676 |
| Other Non-current Liabilities | 49209006 | 36028644 |
| Deferred Income Taxes | 908922 |  |
| Redeemable Non-controlling Interest | 3102213 |  |
| Shareholders' Investment | 2487829724 | 2467950655 |
| Non-Controlling Interest |  | 4149000 |
| Total Liabilities, Redeemable Non-controlling interest, & Shareholders' Investment | $2928592834 | $2760820975 |

---

------

**Exhibit 99.1**

**GENTEX CORPORATION AND SUBSIDIARIES**

**RECONCILIATION OF NON-GAAP MEASURES** 

**(Unaudited)**

In this press release, the Company has provided information regarding certain non-GAAP financial measures, which are reconciled to their closest GAAP financial measure in the following schedules. Use of the term "adjusted" or "excluding," as appropriate, in connection with a financial measure can identify and reflect a non-GAAP financial measure.

**<u>Non-GAAP Financial Measures:</u>** The Company has presented Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Operating Expenses, and Adjusted Income from Operations as supplemental measures of the Company's performance. Current year Adjusted Gross Profit, Adjusted Gross Margin, Adjusted Operating Expenses, and Adjusted Income from Operations exclude certain purchase price adjustments pursuant to ASC 805, acquisition related costs, severance costs, and impairment charges set forth in the table below. Adjusted Gross Margin is defined as Adjusted Gross Profit divided by Net Sales.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **Twelve Months Ended December 31,** | **Twelve Months Ended December 31,** |
| |<br>**Gentex** |<br>**VOXX** | **Consolidated 2025** | **Consolidated 2024** |
| Gross Profit - GAAP | $787399074 | $79309866 | $866708940 | $771090190 |
| Inventory purchase price step-up adjustments pursuance to ASC 805 | $398301 | 2498442 | 2896743 |  |
| Adjusted Gross Profit - (Non-GAAP) | $787797375 | $81808308 | $869605683 | $771090190 |
| Gross Margin - GAAP | 34.7% | 29.7% | 34.2% | 33.3% |
| Adjusted Gross Margin - (Non-GAAP) | 34.7% | 30.6% | 34.3% | 33.3% |
| Operating Expenses - GAAP | 318453383 | 74319803 | 392773186 | 311363617 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition Related Costs | 2316164 | 1515844 | 3832008 | 1866998 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance Costs | 10432974 | 1211764 | 11644738 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment Charges |  |  |  | 8864704 |
| Adjusted Operating Expenses - (Non-GAAP) | $305704245 | $71592195 | $377296440 | $300631915 |
| Income from Operations - GAAP | 468945691 | 4990063 | 473935754 | 459726573 |
| Inventory purchase price step-up adjustments pursuance to ASC 805 | 398301 | 2498442 | 2896743 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition Related Costs | 2316164 | 1515844 | 3832008 | 1866998 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance Costs | 10432974 | 1211764 | 11644738 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment Charges |  |  |  | 8864704 |
| Adjusted Income from Operations - (Non-GAAP) | $482093130 | $10216113 | $492309243 | $470458275 |

---

------

**Exhibit 99.1**

**<u>Adjusted Net Income and Adjusted Earnings per Diluted Share:</u>** Adjusted Net Income and Adjusted Earnings per Diluted Share are presented as supplemental measures of the Company's performance. Adjusted Net Income is defined as Net Income adjusted for purchase price adjustments pursuant to ASC 805, acquisition related costs, severance costs, and impairment charges during the twelve months ended December 31, 2025. Adjusted Earnings per Diluted Share is defined as Adjusted Net Income divided by weighted average diluted shares outstanding.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | **Twelve Months Ended December 31,** | **Twelve Months Ended December 31,** |
| |<br>**Gentex** |<br>**VOXX** | **2025 Consolidated** | **2024 Consolidated** |
| Net Income Attributable to Gentex Corporation - GAAP | $378714570 | $6126797 | $384841367 | $404487743 |
| Inventory purchase price step-up adjustments pursuance to ASC 805, net of tax (1) | 332183 | 2083701 | 2415884 |  |
| Acquisition Related Costs, net of tax (1) | 1931681 | 1264214 | 3195895 | 1600017 |
| Severance Costs, net of tax (1) | 8701100 | 1010611 | 9711711 |  |
| Impairment Charges, net of tax (1) |  |  |  | 7597051 |
| Adjusted Net Income Attributable to Gentex Corporation - (Non-GAAP) | $389679534 | $10485323 | $400164857 | $413684811 |
| Adjusted Earnings Per Share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.76 | $0.05 | $1.81 | $1.81 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.76 | $0.05 | $1.81 | $1.81 |
| (1) Tax effect adjustments are made using the Company's effective tax rate and such rate reasonably reflects the tax effects of applicable adjustments.  | (1) Tax effect adjustments are made using the Company's effective tax rate and such rate reasonably reflects the tax effects of applicable adjustments.  | (1) Tax effect adjustments are made using the Company's effective tax rate and such rate reasonably reflects the tax effects of applicable adjustments.  | (1) Tax effect adjustments are made using the Company's effective tax rate and such rate reasonably reflects the tax effects of applicable adjustments.  | (1) Tax effect adjustments are made using the Company's effective tax rate and such rate reasonably reflects the tax effects of applicable adjustments.  |

---

The Company believes that the presentation of the foregoing non-GAAP financial measures provides insight into the Company's core performance and trends with respect to the same. Management of the Company similarly uses such non-GAAP financial measures in assessing the business internally.

<br>